The Toxicology of Mercury - Current Exposures and Clinical Manifestations

New England Journal of Medicine

Volumn 349, Issue 18, 2003, Pages 1731-1737

  Clarkson, Thomas W ^a   Magos, Laszlo ^b   Myers, Gary J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DENTAL ALLOY; ETHYLMERCURY DERIVATIVE; MERCURY; METHYLMERCURY; THIOMERSAL; VACCINE;

ACRODYNIA; ASTHENIA; CLINICAL FEATURE; ELECTRIC BATTERY; HUMAN; HYPERTENSION; IRRITABILITY; KIDNEY INJURY; MERCURIALISM; OCCUPATIONAL EXPOSURE; PHOTOPHOBIA; POPULATION EXPOSURE; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SEA FOOD; SPHYGMOMANOMETER; THERMOMETER; VAPOR; WORLD HEALTH ORGANIZATION;

ADULT; ANIMALS; DENTAL AMALGAM; FETUS; FISHES; HUMANS; INFANT; MERCURY; MERCURY POISONING; METHYLMERCURY COMPOUNDS; OCCUPATIONAL EXPOSURE; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL;

EID: 0142213730     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra022471     Document Type: Review

References (52)

1. Toxicological profile for mercury. Atlanta: Agency for Toxic Substances Disease Registry, 1999.
2. Evaluation of certain food additives and contaminants: twenty-second report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organ Tech Rep Ser 1978;631:1-39.
3. Environmental Protection Agency. Reference dose for chronic oral exposure to methylmercury. Greenbelt, Md.: Integrated Risk Information System, 2001.
4. Gossel TA, Bricker JD. Principles of clinical toxicology. 2nd ed. New York: Raven Press, 1990.
5. Inorganic mercury. Vol. 118 of Environmental health criteria. Geneva: World Health Organization, 1991.
6. Second national report on human exposure to environmental chemicals. Atlanta: Centers for Disease Control and Prevention, 2003. (Accessed October 6, 2003, at http://www.cdc.gov/exposurereport/.)
7. Brune D, Nordberg GF, Vesterberg O, Gerhardsson L, Wester PO. A review of normal concentrations of mercury in human blood. Sci Total Environ 1991;100:235-82.
8. Methylmercury. Vol. 101 of Environmental health criteria. Geneva: World Health Organization, 1990.
9. Forman J, Moline J, Cernichiari E, et al. A cluster of pediatric metallic mercury exposure cases treated with meso-2,3-dimercaptosuccinic acid (DMSA). Environ Health Perspect 2000;108:575-7.
10. Bluhm RE, Bobbitt RG, Welch LW, et al. Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. I. History, neuropsychological findings and chelator effects. Hum Exp Toxicol 1992;11:201-10.
11. Nierenberg DW, Nordgren RE, Chang MB, et al. Delayed cerebellar disease and death after accidental exposure to dimethylmercury. N Engl J Med 1998;338:1672-6.
12. Pfab R, Muckter H, Roider G, Zilker T. Clinical course of severe poisoning with thiomersal. J Toxicol Clin Toxicol 1996;34:453-60.
13. Magos L, Brown AW, Sparrow S, Bailey E, Snowden RT, Skipp WR, The comparative toxicology of ethyl- and methylmercury. Arch Toxicol 1985;57:260-7.
14. Warkany J, Hubbard DM. Acrodynia and mercury. J Pediatr 1953;42:365-86.
15. Kingman A, Albertini T, Brown LJ. Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J Dent Res 1998;77:461-71.
16. Sallsten G, Thoren J, Barregard L, Schutz A, Skarping G. Long-term use of nicotine chewing gum and mercury exposure from dental amalgam fillings. J Dent Res 1996;75: 594-8.
17. Molin M, Bergman B, Marklund SL, Schutz A, Skerfving S. Mercury, selenium, and glutathione peroxidase before and after amalgam removal in man. Acta Odontol Scand 1990;48:189-202.
18. Ramazzini B. Diseases of workers. Wright WC, trans. New York: Hafner Publishing, 1964.
19. Ahlqwist M, Bengtsson C, Lapidus L, Gergdahl IA, Schutz A. Serum mercury concentration in relation to survival, symptoms, and disease: results from the prospective population study of women in Gothenburg, Sweden. Acta Odontol Scand 1999;57:168-74.
20. Bjorkman L, Pedersen NL, Lichtenstein P. Physical and mental health related to dental amalgam fillings in Swedish twins. Community Dent Oral Epidemiol 1996;24:260-7.
21. Saxe SR, Snowdon DA, Wekstein MW, et al. Dental amalgam and cognitive function in older women: findings from the Nun Study. J Am Dent Assoc 1995;126:1495-501.
22. Leong CC, Syed NI, Lorscheider FL. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport 2001;12:733-7.
23. Gibson R, Taylor TS. Nicor says mercury spilled at more sites: contamination found at 6 new locations, company tells state. Chicago Tribune (Sports Final Edition Section, zone N). September 14, 2000:1.
24. Riley DM, Newby CA, Leal-Almeraz TO, Thomas VM. Assessing elemental mercury vapor exposure from cultural and religious practices. Environ Health Perspect 2001;109: 779-84.
25. Goldwater LJ. Mercury: a history of quicksilver. Baltimore: York Press, 1972.
26. Jernelöv A. Conversion of mercury compounds. In: Miller MW, Berg GG, eds. Chemical fallout: current research on persistent pesticides. Springfield, Ill.: Charles C Thomas, 1969:68-74.
27. Johnels AG, Westermark T. Mercury contamination of the environment in Sweden. In: Miller MW, Berg GG, eds. Chemical fallout: current research on persistent pesticides. Springfield, Ill.: Charles C Thomas, 1969:221-41.
28. Hunter D. The diseases of occupations. 4th ed. London: English Universities Press, 1969:314-28.
29. Bakir F, Damluji SF, Amin-Zaki L, et al. Methylmercury poisoning in Iraq. Science 1973;181:230-41.
30. Eto K, Oyanagi S, Itai Y, Tokunaga H, Takizawa Y, Suda I. A fetal type of Minamata disease: an autopsy case report with special reference to the nervous system. Mol Chem Neuropathol 1992;16:171-86.
31. Likosky WH, Hinman AR, Barthel WF. Organic mercury poisoning, New Mexico. Neurology 1970;20:401.
32. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 2002;347: 1747-54.
33. Yoshizawa K, Rimm EB, Morris JS, et al. Mercury and the risk of coronary heart disease in men. N Engl J Med 2002;347:1755-60.
34. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 2000;148:265-73.
35. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 1995;91:645-55.
36. Sorensen N, Murata K, Budtz-Jorgensen E, Weihe P, Grandjean P. Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology 1999;10:370-5.
37. Blood and hair mercury levels in young children and women of childbearing age - United States, 1999. JAMA 2001;285:1436-7.
38. Bolger PM, Schwetz BA. Mercury and health. N Engl J Med 2002;347:1735-6.
39. Kjellstrom T, Kennedy P, Wallis S, et al. Physical and mental development of children with prenatal exposure to mercury from fish. Stage 2. Interviews and psychological tests at age 6. Report no. 3642. Solna, Sweden: Solna National Swedish Environmental Board, 1989.
40. Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997;19:417-28.
41. Myers GJ, Davidson PW, Cox C, et al. Prenatal methylmercury exposure from ocean fish consumption: 9-year evaluations in the Seychelles child development study. Lancet 2003;361:1686-92.
42. Water quality criterion for the protection of human health: methylmercury. Washington, D.C.: Environmental Protection Agency, January 2001. (EPA-823-R-01-001.)
43. Board on Environment studies and toxicology. Toxicological effects of methyl mercury. Washington, D.C.: National Research Council, 2000.
44. Grandjean P, Weihe P, Jorgensen PL, Clarkson T, Cernichiari E, Videro T. Impact of maternal seafood diet on fetal exposure to mercury, selenium, and lead. Arch Environ Health 1991;47:185-95.
45. Magos L. Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical preparations. J Appl Toxicol 2001;21:1-5.
46. Clarkson TW. The three modern faces of mercury. Environ Health Perspect 2002;110: Suppl 1:11-23.
47. USP 24-NF 19: U.S. Pharmacopeia and national formulary. 24th ed. Rockville, Md.: United States Pharmacopeial Convention, 1999.
48. Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines. Pediatrics 2001;107:1147-54.
49. Freed GL, Andreae MC, Cowan AE, Katz SL. The process of public policy formulation: the case of thimerosal in vaccine. Pediatrics 2002;109:1153-9.
50. Pichichero ME, Cernichiari E, Lopricato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet 2002;360:1737-41.
51. Smith J, Farris FF. Methyl mercury pharmacokinetics in man: a reevaluation. Toxicol Appl Pharmacol 1996;137:245-52.
52. Vaccines and biologicals: recommendations from the Strategic Advisory Group of Experts. Wkly Epidemiol Rec 2002;77:305-12.